Brookfield Corp’s Organon & Co OGN Stock Holding History

Brookfield Corp’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-163,591	Closed	-$5.52M	–	735
2022 Q2	$5.52M	Buy	+163,591	New	+$5.73M	0.02%	234

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brookfield Corp's OGN Position: Q3 2022 in Review

Brookfield Corp sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 163,591 shares — an estimated $5.52M sold.

Brookfield Corp first reported a position in OGN in Q2 2022 and held it in 1 quarter. The position peaked at $5.52M in Q2 2022. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

Brookfield Corp reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
Brookfield Corp sold 163,591 Organon & Co shares in Q3 2022, an estimated $5.52M.
Brookfield Corp first reported a position in Organon & Co in Q2 2022 and held it in 1 quarter.
Brookfield Corp's Organon & Co position peaked at $5.52M in Q2 2022.
791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Brookfield Corp's 13F filing for Q3 2022, filed 14 Nov 2022.